Table 1.

General Characteristics of Study Participants

Variable	All (n=897)	Females (n=323)	Males (n=574)	P-value
Age (yrs)	44.7 (10.1)	45.2 (10.1)	44.4 (10.1)	0.19
Age at HIV (yrs)	37.9 (10.7)	38.2 (10.9)	37.7 (10.5)	0.70
CD4 (cells/μL)	473 (322)	486 (326)	467 (320)	0.55
<200	19%	16%	20%	0.22
201–500	41%	44%	40%
>500	40%	40%	40%
HIV RNA (copies/ml)
Non detectable	51%	48%	52%	0.27
<1,000	13%	14%	12%
1,000 – 30,000	21%	23%	19%
>30,000	16%	14%	17%
Education ≥ High School (%)	56	48	60	<0.001
Smokers (%)	50	44	53	0.01
Alcohol abuse (%)	39	27	45	<0.001
Hepatitis C (%)	21	17	23	0.06
HAART-Naïve (%)	10	10	9	0.75
PI Only (%)	3	2	3	0.82
NRTI/NNRTI Only (%)	34	38	32	0.07
HAART (%)	45	42	46	0.31

Data are given as mean (SD) except when noted. HAART= highly active antiretroviral therapy, PI= protease inhibitors, NRTI/NNRTI= nucleoside and non-nucleoside reverse transcriptase inhibitors